JP2015510517A5 - - Google Patents

Download PDF

Info

Publication number
JP2015510517A5
JP2015510517A5 JP2014557799A JP2014557799A JP2015510517A5 JP 2015510517 A5 JP2015510517 A5 JP 2015510517A5 JP 2014557799 A JP2014557799 A JP 2014557799A JP 2014557799 A JP2014557799 A JP 2014557799A JP 2015510517 A5 JP2015510517 A5 JP 2015510517A5
Authority
JP
Japan
Prior art keywords
composition
unsubstituted
substituted
als
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014557799A
Other languages
English (en)
Japanese (ja)
Other versions
JP6173352B2 (ja
JP2015510517A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/026284 external-priority patent/WO2013123290A1/en
Publication of JP2015510517A publication Critical patent/JP2015510517A/ja
Publication of JP2015510517A5 publication Critical patent/JP2015510517A5/ja
Application granted granted Critical
Publication of JP6173352B2 publication Critical patent/JP6173352B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014557799A 2012-02-15 2013-02-15 筋萎縮性側索硬化症の治療方法 Expired - Fee Related JP6173352B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261599096P 2012-02-15 2012-02-15
US61/599,096 2012-02-15
PCT/US2013/026284 WO2013123290A1 (en) 2012-02-15 2013-02-15 Methods of treating amyotrophic lateral sclerosis

Publications (3)

Publication Number Publication Date
JP2015510517A JP2015510517A (ja) 2015-04-09
JP2015510517A5 true JP2015510517A5 (https=) 2016-03-24
JP6173352B2 JP6173352B2 (ja) 2017-08-02

Family

ID=48984729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014557799A Expired - Fee Related JP6173352B2 (ja) 2012-02-15 2013-02-15 筋萎縮性側索硬化症の治療方法

Country Status (5)

Country Link
US (1) US9340483B2 (https=)
EP (1) EP2814479B1 (https=)
JP (1) JP6173352B2 (https=)
CA (1) CA2864797C (https=)
WO (1) WO2013123290A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7689356B2 (ja) * 2017-01-18 2025-06-06 ウニヴェルジテート オートノマ デ バルセロナ 神経変性疾患及び/又は自己免疫性疾患の処置において使用するための抗炎症性脂質メディエーター
US11583511B2 (en) 2017-07-20 2023-02-21 Universitat Autonoma De Barcelona Maresins for use in the treatment of CNS injuries
US10322114B2 (en) 2017-07-31 2019-06-18 Above And Beyond Nb, Llc Formulation of a riluzole solution with beta-cyclodextrins
US20250381161A1 (en) * 2022-06-21 2025-12-18 Anida Pharma Inc. Compositions and methods for treating hearing and ocular disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4932116B2 (ja) 2000-02-16 2012-05-16 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド アスピリン誘発脂質メディエータ
US7030126B2 (en) * 2001-11-16 2006-04-18 Als Therapy Development Foundation, Inc. Use of polyamine analogs for amyotrophic lateral sclerosis
US7759395B2 (en) 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
WO2004093802A2 (en) 2003-04-17 2004-11-04 The Board Of Trustees Of The Leland Stanford Junior University Prevention of deficits in neurogenesis with anti-inflammatory agents
EP1660069A4 (en) * 2003-08-05 2009-03-18 Univ Louisiana State NEUROPROTECTION AGAINST CELL APOPTOSIS, NEURAL STROKES, ALZHEIMER DISEASE AND RETINAL DEGENERATION
SI1691814T1 (sl) * 2003-12-01 2012-11-30 Cambridge Entpr Ltd Protivnetna zdravila
US8273792B2 (en) * 2005-10-03 2012-09-25 The Brigham And Women's Hospital, Inc. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers
EP2120920A4 (en) * 2007-02-20 2011-06-15 Martek Biosciences Corp OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
CA2723139A1 (en) * 2007-07-30 2009-02-05 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Dha and pedf, a therapeutic composition for nerve and retinal pigment epithelial cells
GB2452696B (en) * 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
CA2699483A1 (en) 2007-09-14 2009-03-26 Resolvyx Pharmaceuticals, Inc. Compositions and methods for modulating immune function
EP2217558A1 (en) 2007-10-31 2010-08-18 Pronova Biopharma Norge AS New dha derivatives and their use as medicaments
US7782152B2 (en) 2008-08-14 2010-08-24 Broadcom Corporation Monotonic frequency tuning technique for DCXO in cellular applications
US20120122816A1 (en) 2009-02-05 2012-05-17 Resolvyx Pharmaceuticals, Inc. Compositions and methods for organ preservation
USRE48077E1 (en) * 2013-02-28 2020-07-07 Anida Pharma Inc. Methods of treating ototoxicity

Similar Documents

Publication Publication Date Title
JP2008195730A5 (https=)
JP6772272B2 (ja) シクロヘキサン誘導体、又はその立体異性体、又はその塩及びその調製と応用
JP6021805B2 (ja) 腫瘍治療剤
JP2018524339A5 (https=)
TWI633887B (zh) 用於預防及/或治療多囊性腎臟病之藥物
JP2013528600A5 (https=)
JP2014516942A5 (https=)
JP2009102342A5 (https=)
JP2014508804A5 (https=)
MX356032B (es) Compuestos indola y métodos para tratar el dolor visceral.
JP2019515884A5 (https=)
BR112014020345B1 (pt) Composto antiviral, composição farmacêutica compreendendo dito composto e uso dos mesmos para tratar infecção viral ou doença associada à mesma
JP2017511360A5 (https=)
JP2013510825A5 (https=)
JP2013514980A5 (https=)
TN2013000257A1 (en) Immunosuppressant formulations
JP2015510517A5 (https=)
JP2011526286A5 (https=)
WO2022178420A1 (en) Rock2 inhibitor for the treatment of viral infection
JP2010514734A (ja) 腸障害の治療のためのイソソルビドモノニトレート誘導体
RU2012146874A (ru) Производные пиразолопиридина
JP2015522592A5 (https=)
US12414935B2 (en) Compounds and methods for the treatment of parasitic diseases
JP2012504584A5 (https=)
JP2013525290A5 (https=)